日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

KRAS(G12/13) mutation modulates CRC outcomes via disrupting positive feedback between macrophage and CD4(+) T cell.

KRAS(G12/13)突变通过破坏巨噬细胞和CD4(+) T细胞之间的正反馈来调节CRC的结果。

Yan Xuehan, Su Juncheng, Liu Hongyuan, Yuan Tianli, Zhong Yiqing, Xie Tian, Wang Zheng

Ferroptosis resistance-related TEP1 as a novel prognostic biomarker involved in immune cell infiltration and tumour progression in glioblastoma

铁死亡抵抗相关TEP1作为一种新型预后生物标志物,参与胶质母细胞瘤的免疫细胞浸润和肿瘤进展

Kunxiang Chen #,Chengzong Zhong #,Yiqing Wang #,Tao Liu,Huan Chen,Ruizhi Wu,Guanping Qiu,Siqi Zheng,Yong Gao,Yuean Ping,Qiang Zhou,Yuntao Lu,Hong Li

High extracellular matrix stiffness upregulates TNNT1 to awaken dormant tumor cells in liver metastatic niches of gastric cancer.

细胞外基质硬度高可上调 TNNT1,从而唤醒胃癌肝转移灶中休眠的肿瘤细胞

Ji Linhua, Peng Jie, Lin Yuxuan, Zhong Yiqing, Ni Bo, Zhu Chunchao, Zhang Zizhen

Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer

衰老风险评分:一种预测结直肠癌预后、干细胞特性和免疫反应的多方面预后工具

Zhang, Xiaojun; Huang, Yilan; Li, Qian; Zhong, Yiqing; Zhang, Yuanzhou; Hu, Jingying; Liu, Rui; Luo, Xiaoying

ANKRD22 Drives Rapid Proliferation of Lgr5+ Cells and Acts as a Promising Therapeutic Target in Gastric Mucosal Injury

ANKRD22 促进 Lgr5+ 细胞快速增殖,成为胃粘膜损伤的有希望的治疗靶点

Jingwen Liu, Jingni Wu, Rui Wang, Dandan Zhong, Yiqing Qiu, Hongping Wang, Zhenya Song, Yongliang Zhu